Warning letter
PLIVA, Inc.: warning letter of Oct 3, 2003
FDA warning letter UCM147756 · New Jersey District Office
Key facts
| Reference number | UCM147756 |
|---|---|
| Company | PLIVA, Inc. |
| Subject | GMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Oct 3, 2003 |
| Posted date | Oct 3, 2003 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| CFR sections cited | 211.160(a), 211.63, 211.192, 211.198, 211.194(a)(5) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: